Journal of Medicinal Chemistry p. 7669 - 7678 (2013)
Update date:2022-07-30
Topics:
Hinklin, Ronald J.
Boyd, Steven A.
Chicarelli, Mark J.
Condroski, Kevin R.
Dewolf, Walter E.
Lee, Patrice A.
Lee, Waiman
Singh, Ajay
Thomas, Laurie
Voegtli, Walter C.
Williams, Lance
Aicher, Thomas D.
Glucose flux through glucokinase (GK) controls insulin release from the pancreas in response to high glucose concentrations. Glucose flux through GK also contributes to reducing hepatic glucose output. Because many individuals with type 2 diabetes appear to have an inadequacy or defect in one or both of these processes, compounds that can activate GK may serve as effective treatments for type 2 diabetes. Herein we report the identification and initial optimization of a novel series of allosteric glucokinase activators (GKAs). We discovered an initial thiazolylamino pyridine-based hit that was optimized using a structure-based design strategy and identified 26 as an early lead. Compound 26 demonstrated a good balance of in vitro potency and enzyme kinetic parameters and demonstrated blood glucose reductions in oral glucose tolerance tests in both C57BL/6J mice and high-fat fed Zucker diabetic fatty rats.
View MoreNANCHANG QINZHI SCI&TEC.CO.,LTD
Contact:+86-13687004106
Address:Hero South Road,Hero Zone,Nanchang,Jiangxi,China
Xi'an caijing Opto-Electrical Science & Technology Co., LTD
Contact:+86-29-88294447
Address:NO.168 Zhangba Rd. East, Xi'an, P.R.China
Changde Yungang Biotechnology Co., Ltd
website:http://www.cdyg.com
Contact:+86-736-7391178
Address:Qiaonan Industrial Park, Changde City, Hunan Province
Contact:+86-25-85281586
Address:13F,Bld2#,South of Longpan Road
Contact:+86-577-65618087-605
Address:Room 402, Unit 4 Xinhu Bldg. Waitan Ruian City, Zhejiang China.
Doi:10.1016/j.tet.2006.10.090
(2007)Doi:10.1002/oms.1210100403
(1975)Doi:10.1002/ejoc.200600959
(2007)Doi:10.1002/anie.201003819
(2010)Doi:10.1515/chempap-2015-0055
(2015)Doi:10.1002/anie.200502240
(2005)